课题基金 / 基金详情

The role of RNA in the response to cellular stress

The role of RNA in the response to cellular stress
RNA 在细胞应激反应中的作用
批准号:
MC_UU_00025/6
负责人:
Martin Bushell
金额:
$9.68万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Martin Bushell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recently, a new gene delivery system has been developed, to specifically provide diseased cells with a particular protein to correct cell function. This method using messenger RNA molecules as a delivery vehicle. By changing the RNA molecules different proteins can be encoded on these RNA molecules and different human disease can be treated. However, our lack of understanding of these molecules has resulted in safety issue, which need to be resolved before they can be used to treat a large range of human diseases. Our laboratory has been investigating how RNAs are regulated and we have discovered that two particular RNA binding proteins associate with translationally repressed mRNAs. Using methods developed in our laboratory we can now identify RNA repression mechanisms operating in different tissues and thus tailor these RNA molecules for specific delivery to different tissue types, reducing toxic side effects. We will determine the applicability of this approach to identify the repertoire of repressive mechanisms operating within a cell, in order to engineer therapeutic-mRNAs for restricted on-target expression in particular tissues/cell types and disease states. This will facilitate the development of the next generation of mRNA-based therapeutics which will be specifically designed to minimise potential off-target adverse effects.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.dnarep.2021.103158
发表时间: 2021-09
期刊: DNA repair
影响因子: 3.8
作者: [Bader AS, Bushell M]
通讯作者: Bushell M
DOI: 10.1093/nar/gkac843
发表时间: 2022-10-14
期刊: NUCLEIC ACIDS RESEARCH
影响因子: 14.9
作者: [Bader, Aldo S., Luessing, Janna, Hawley, Ben R., Skalka, George L., Lu, Wei-Ting, Lowndes, Noel F., Bushell, Martin]
通讯作者: Bushell, Martin
DOI: 10.1038/s41467-018-02893-x
发表时间: 2018-02-07
期刊: Nature communications
影响因子: 16.6
作者: [Lu WT, Hawley BR, Skalka GL, Baldock RA, Smith EM, Bader AS, Malewicz M, Watts FZ, Wilczynska A, Bushell M]
通讯作者: Bushell M
DOI: 10.1038/s41419-018-0628-4
发表时间: 2018-05-29
期刊: Cell death & disease
影响因子: 9
作者: [Godfrey JD, Morton JP, Wilczynska A, Sansom OJ, Bushell MD]
通讯作者: Bushell MD
8
    The impact and regulation of eIF4A-multimerisation in establishing translational programmes
    • 批准号:
      BB/Y004248/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $66.14万
    • 财政年份:
      2024
    • 负责人:
      Martin Bushell
    • 依托单位:
    The role of the CCR4-NOT complex and mRNA regulatory elements in determining protein synthesis, destination and complex formation.
    • 批准号:
      BB/W016265/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $56.27万
    • 财政年份:
      2023
    • 负责人:
      Martin Bushell
    • 依托单位:
    The role of poly(A) tail metabolism in gene expression
    • 批准号:
      BB/V000209/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $28.75万
    • 财政年份:
      2021
    • 负责人:
      Martin Bushell
    • 依托单位:
    Mechanistic determination of how microRNAs control gene-expression
    • 批准号:
      BB/N017005/2
    • 项目类别:
      Research Grant
    • 资助金额:
      $43.14万
    • 财政年份:
      2018
    • 负责人:
      Martin Bushell
    • 依托单位:
    国内基金
    海外基金
    基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      程子译
    • 依托单位:
    RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
    • 批准号:
      2026JJ81091
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘亮
    • 依托单位:
    免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
    • 批准号:
      2026JJ50010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      应站明
    • 依托单位:
    Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
    • 批准号:
      JCZRLH202600588
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: